Although the reduction observed at center B did not reach statistical significance in the direct comparison with center A, the average number of AE issues per subject at center B (2.33) remained substantially lower than that observed at the other centers (5.60).
← all excerpts
Qualitative Analysis of One Phase II Clinical Trial for the Drug Treatment of Large-Area Cerebral Infarction.
1
—
—